NEW YORK, January 3, 2026, 05:50 ET — Market closed
- Occidental shares ended Friday up 3.06% at $42.38
- Company completed the $9.7 billion all-cash sale of OxyChem to Berkshire Hathaway
- Investors are watching how quickly proceeds show up in debt metrics and shareholder returns
Occidental Petroleum shares ended Friday up 3.06% at $42.38 after the company completed a $9.7 billion all-cash sale of its OxyChem chemicals business to Berkshire Hathaway. A regulatory filing showed Occidental published unaudited pro forma financial statements, which adjust past results as if the sale and certain debt redemptions had already happened. The stock’s 52-week range is $34.78 to $53.20, according to the company’s investor site. Oxy
The divestiture — the sale of a business — delivers a large cash inflow and reshapes Occidental into a tighter oil-and-gas story. That matters early in 2026 as investors keep pressing energy companies to prioritize balance-sheet strength and cash returns over aggressive growth. Leverage, a measure of debt relative to earnings, remains a key pressure point when crude prices are volatile.
Chief executive Vicki Hollub said the transaction would “strengthen Occidental’s balance sheet” and sharpen its focus on the company’s oil-and-gas portfolio. Occidental also said a subsidiary retained certain legacy tort claims and environmental liabilities tied to historical operations and expects to spend remediation money over many years. SEC
The pro forma snapshots give investors a clearer way to model what earnings and cash flow might look like without the chemicals unit. They also help frame how quickly Occidental can translate the cash proceeds into lower net debt — and what that means for capital returns.
The move came during a firm session for U.S. stocks, with the S&P 500 up 0.19% and the Dow adding 0.66%. Energy peers also gained, including Chevron, up 2.29%, and Devon Energy, up 3.39%. MarketWatch
Crude prices were subdued: front-month WTI was at $57.33 a barrel, down 0.16%, and Brent last-day financial futures were at $60.79, down 0.10%, CME data showed. CME Group
Occidental’s rise despite softer crude highlighted how deal-driven catalysts can swamp the commodity tape on a given day. Over time, though, shedding OxyChem reduces diversification and can make quarterly results more sensitive to oil-and-gas price swings.
The retained liabilities are the counterweight to the cash headline. Investors will be watching for future disclosures on how remediation obligations affect free cash flow, the cash left after capital spending.
Traders are also looking for clearer signals on capital allocation — whether proceeds go first to debt reduction, share repurchases, or reinvestment in the upstream business, the company’s oil-and-gas production arm.
Before the next session, attention will shift to the next earnings window; Nasdaq’s earnings calendar lists an estimated Feb. 17 report date, noting the timing is algorithm-based rather than company-confirmed. Nasdaq
Macro remains in the mix as the first full trading week of the year approaches, with investors watching for the Federal Reserve’s next policy signals and for U.S. economic data expected to resume after releases were delayed by a government shutdown, a Reuters report said. Oil’s oversupply worries are also keeping energy stocks sensitive to any shift in the crude outlook. Reuters
